Drug Profile
DS 11960558
Alternative Names: DS11960558; Prodrug of DS 2969bLatest Information Update: 28 Nov 2021
Price :
$50
*
At a glance
- Originator Daiichi Sankyo Company
- Class Antibacterials; Antidiarrhoeals
- Mechanism of Action DNA gyrase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Clostridium difficile infections
Most Recent Events
- 28 Nov 2021 No recent reports of development identified for preclinical development in Clostridium-difficile-infections in Japan (IV)
- 04 Oct 2017 Preclinical trials in Clostridium difficile infections in Japan (IV)
- 04 Oct 2017 Pharmacodynamics, safety and pharmacokinetics data from a preclinical study in Clostridium difficile infections presented at the IDWeek 2017